9158
Fiscal year ends March Quarters are offset from the calendar — Q1 is Apr–Jun

CUC Inc. is a healthcare services and consulting group operating across four main segments: medical institution management, hospice care, home visiting nursing, and medical care residences. In the medical institution segment, the company provides operational support, strategic planning, and M&A advisory services to hospitals and clinics in Japan, while directly operating podiatry and lower limb vein disease clinics in the United States and primary care clinics in Vietnam. The hospice segment manages residential facilities for patients with terminal cancer or neurodegenerative diseases, offering 24/7 visiting nursing and care services. The home visiting nursing segment operates large-scale stations providing round-the-clock nursing, rehabilitation, and home-based clinical trial support. The medical care residence segment operates senior housing and service apartments for elderly residents requiring high levels of care, supplemented by rehabilitation-focused day services and a proprietary medication management system. Key subsidiaries include CUC Podiatry Holdings, LLC, CUC SINGAPORE PTE.LTD., and Sophia Medical Co., Ltd.

Summarised from the annual report, fiscal year ended Mar 2026

Industry Medical Care Facilities Homepage cuc-jpn.com
Sector Healthcare IR page cuc-jpn.com/ir
Tags
hospice care, visiting nursing, senior housing, medical consulting, podiatry, home-based clinical trials, medication management, rehabilitation services, primary care, healthcare m&a, CUC Podiatry Holdings LLC, CUC SINGAPORE PTE.LTD., Sophia Medical Co. Ltd., Tokyo Family Clinic, Beyond Podiatry, Central DuPage Foot & Ankle Associates, CUC America Inc., CUC Advisory Partners, CUC Hospice, CUC Data, CUC Foods, CUC Properties, CUC Dialysis Research & Development, KEEP, Noa Concert, Amur Life Nishigaoka Field, Fukuyakun, Honobono NEXT, NRHA, CUC Partners Philosophy, Challenge!
Press page cuc-jpn.com/en/ir/news

Metrics

Valuation  
Market cap ¥ 23.333B
Market cap (USD) $ 145.83M
P/E 10.66
PEG 1.90
P/BV 0.68
P/S 0.41
P/OCF 3.96
P/FCF 3.21
Dividend yield —
Turnover / mcap —
Returns  
ROE 8.9%
ROI 4.3%
ROIC 4.7%
Profit margin 5.3%
Growth  
Revenue growing Yes
Profits growing No
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) 5.6%
Quality  
Profitable Yes
Margin expanding No
Buying back stock No
Diluting (TTM) No
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 1
Quality score 11.8%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Revenue 54.353B 47.043B 33.025B 35.21B 35.314B 16.606B 3.818B 3.066B
Net profit 2.854B 3.131B 2.595B 2.423B 2.707B 1.1B 122M 511M
Free cash flow 5.584B 2.463B -747M -3.095B — — — —

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Share price 868.72 1.372K 2.703K — — — — —
Price performance 12m -0.37 -0.49 — — — — — —

Filed figures

Figure Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Balance sheet detail
Trade receivables (JPY) 10.5B 8.24B 8.76B 12.2B 13.1B
↳ YoY growth -21.6% +6.3% +38.7% +7.7%
Borrowings, current (JPY) 10.7B 16B 2B 2.81B 3.69B
Borrowings, non-current (JPY) — — 16.4B 20.7B 28.6B
Lease liabilities (JPY) 4.22B 5.41B 8.29B 20.1B 20.3B
Cash and deposits (JPY) 4.36B 4.12B 8.26B 7.53B 15.8B
Intangible assets (JPY) 2.67B 2.78B 4.42B 4.31B 4.17B
Right-of-use assets (JPY) 3.64B 4.71B 7.67B 19.4B 19.3B
Net debt (borrowings + leases - cash) (JPY) 10.5B 17.3B 18.5B 36B 36.7B
Cash flow detail
Operating cash flow (JPY) 6.62B 2.36B 4.16B 2.5B 5.71B
Purchases of property, plant and equipment (JPY) -831M -5.45B -4.86B -5.59B -6.74B
Purchases of intangible assets (JPY) -17M -131M -44M -40M -122M
Change in receivables (cash effect) (JPY) -3.16B 2.58B -53M -2.34B -342M
Change in inventories (cash effect) (JPY) 19M 5M 11M -96M 52M
Change in payables (cash effect) (JPY) 2.94B -2.08B -454M -598M -659M
Interest paid (cash effect) (JPY) -100M -92M -284M -550M -654M
Operating cash flow before change in receivables (JPY) 9.77B -219M 4.21B 4.84B 6.05B
Free cash flow (OCF - PPE - intangibles) (JPY) 5.77B -3.23B -747M -3.12B -1.16B
Income detail
Total comprehensive income (JPY) 4.33B 1.96B 2.54B 2.1B 3.62B
Comprehensive income to owners (JPY) 4.72B 1.97B 2.46B 2.21B 3.61B
Segments
Hospice · Segment revenue (JPY) — 6.63B 10.4B 13.8B 16.7B
↳ YoY growth +56.6% +32.4% +21.5%
Hospice · Segment operating income (JPY) — 191M 349M 1B 980M
In Home Nursing · Segment revenue (JPY) — 12.2B 10.9B 12.3B 12.9B
↳ YoY growth -10.2% +12.5% +5.2%
In Home Nursing · Segment operating income (JPY) — 1.35B 616M 1.21B 1.42B
In Home Nursing Hospice · Segment revenue (JPY) 17.4B 18.8B — — —
↳ YoY growth +8.4%
In Home Nursing Hospice · Segment operating income (JPY) 2.73B 1.54B — — —
Management Support · Segment revenue (JPY) 17.4B 16.4B — — —
↳ YoY growth -5.5%
Management Support · Segment operating income (JPY) 1.4B 2.96B — — —
Medical Care Residence · Segment revenue (JPY) — — — 3.57B 7.7B
↳ YoY growth +116.0%
Medical Care Residence · Segment operating income (JPY) — — — 299M -262M
Medical Institution · Segment revenue (JPY) — 16.4B 12.2B 17.6B 17.3B
↳ YoY growth -25.9% +44.5% -1.7%
Medical Institution · Segment operating income (JPY) — 2.96B 3.93B 3.62B 4.56B
Reported Jun 29, 2023 Jun 27, 2024 Jun 27, 2024 Jun 27, 2025 Jun 25, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

2027年3月期 第2四半期決算説明資料 Bull 0 Bear 5 Results

Prompts

CUC Inc. (ticker 9158), listed in Japan.

ETFs Holding CUC Inc.

ETF Weight in ETF Shares Market value As of
DISV 0.00% 18,300 $ 70.614K Nov 12, 2026
DFIS 0.00% 11,000 $ 42.445K Nov 12, 2026
DFIC 0.00% 600 $ 2,315.20 Nov 12, 2026
AVDV 0.00% 30,900 $ 114.281K Nov 16, 2026
AVDS 0.00% 500 $ 1,849.21 Nov 16, 2026